ars-pharma.com - SPRY Company Cash Volume

Official company branding of ARS Pharmaceuticals, Inc. (SPRY)

Free cash flow reflects the dynamics of liquid reserves, where 0.14 forms the current metric. ARS Pharmaceuticals is currently spending accumulated funds on the launch of a new product, which temporarily outweighs revenue. ARS Pharmaceuticals created Neffy, the first needle-free spray for emergency anaphylaxis treatment. The absence of needles makes the drug unique, allowing the company to establish pricing power based on patient comfort.

SPRY - ARS Pharma Company Cash Volume over the range 04/28/2023 - 11/21/2026

Metric breakdowns and analytics for ARS Pharmaceuticals, Inc. (SPRY)

- stock value and consensus price forecast:
Comprehensive company analysis:ars-pharma.com
Signature product of ars-pharma.com

This metric reflects the net liquidity of ARS Pharmaceuticals (SPRY) excluding borrowed funds, allowing for an assessment of the company's autonomy and its ability to service short-term liabilities. By analyzing the company's cash balance, an investor can correlate capital reserves with the promotion costs of the nasal spray and the pace of its inclusion in insurance formularies to ensure sustainable commercial growth.

Competitors of ARS Pharmaceuticals

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance